Pediatrix Medical Group, Inc. (NYSE:MD) Stock Holdings Increased by XTX Topco Ltd

Key Points

• XTX Topco Ltd increased its holdings in Pediatrix Medical Group by 246.5%, owning a total of 44,752 shares valued at $648,000 as of the end of the most recent quarter.
• Pediatrix Medical Group's stock price rose to $14.48, supported by a market capitalization of $1.24 billion and a price-to-earnings ratio of 11.22.
• The company reported quarterly earnings of $0.53 per share, exceeding estimates, despite a 7.1% year-over-year revenue decrease to $468.84 million.

XTX Topco Ltd boosted its position in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 246.5% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 44,752 shares of the company's stock after acquiring an additional 31,835 shares during the quarter. XTX Topco Ltd owned 0.05% of Pediatrix Medical Group worth $648,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. KLP Kapitalforvaltning AS purchased a new position in Pediatrix Medical Group in the fourth quarter valued at about $235,000. LPL Financial LLC raised its position in Pediatrix Medical Group by 4.9% in the fourth quarter. LPL Financial LLC now owns 92,828 shares of the company's stock valued at $1,218,000 after purchasing an additional 4,295 shares during the period. Vanguard Group Inc. raised its position in Pediatrix Medical Group by 1.1% in the fourth quarter. Vanguard Group Inc. now owns 10,812,611 shares of the company's stock valued at $141,861,000 after purchasing an additional 113,976 shares during the period. Pictet Asset Management Holding SA raised its position in Pediatrix Medical Group by 63.7% in the fourth quarter. Pictet Asset Management Holding SA now owns 14,590 shares of the company's stock valued at $191,000 after purchasing an additional 5,677 shares during the period. Finally, O Shaughnessy Asset Management LLC purchased a new position in Pediatrix Medical Group in the fourth quarter valued at about $242,000. Institutional investors and hedge funds own 97.71% of the company's stock.

Pediatrix Medical Group Stock Down 1.1%

Shares of NYSE MD traded down $0.16 during midday trading on Friday, reaching $14.33. 1,202,160 shares of the company's stock were exchanged, compared to its average volume of 770,154. Pediatrix Medical Group, Inc. has a 52-week low of $9.75 and a 52-week high of $17.67. The stock has a market capitalization of $1.25 billion, a PE ratio of 11.10 and a beta of 1.21. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.81 and a current ratio of 1.80. The business's fifty day moving average price is $13.41 and its two-hundred day moving average price is $13.83.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last announced its earnings results on Tuesday, August 5th. The company reported $0.53 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.42 by $0.11. Pediatrix Medical Group had a return on equity of 18.94% and a net margin of 5.66%. The business had revenue of $468.84 million for the quarter, compared to analyst estimates of $464.37 million. During the same period in the previous year, the company earned $0.34 earnings per share. The company's revenue for the quarter was down 7.1% compared to the same quarter last year. Analysts forecast that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

Wall Street Analysts Forecast Growth

MD has been the topic of several research reports. Truist Financial cut their price objective on Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating on the stock in a research report on Friday, April 11th. Macquarie raised their price objective on Pediatrix Medical Group from $19.00 to $20.00 and gave the company an "outperform" rating in a research report on Thursday, May 8th. Finally, UBS Group cut their price objective on Pediatrix Medical Group from $18.50 to $16.00 and set a "neutral" rating on the stock in a research report on Monday, May 12th. Four investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, Pediatrix Medical Group has an average rating of "Hold" and an average target price of $16.67.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.